Tardive Dyskinesia Associated with High-Dose Intravenous Metoclopramide
NEJM 315:518-519, Breitbart,W., 1986
Nifedipine-Associated Acute Psychosis
Am J Med 81:705-706, Kahn,J.K., 1986
Parkinsonism, Tardive Dyskinesia, Akathisia, & Depression Induced by Flunarizine
Lancet 1:1303-1304, Chouza,C.,et al, 1986
Increased Antidepressant Use in Patients Prescribed B-Blockers
JAMA 255:357-360, Avorn,J.,et al, 1986
The Diagnosis of Myasthenia Gravis
Editorial, Lancet 1:658-6601986., , 1986
Myasthenia Gravis without Acetylcholine-Receptor Antibody:A Distinct Disease Entity
Lancet 1:116-118, Mossman,S.,et al, 1986
Low-Dose Bromocriptine Therapy in Parkinson's Disease:Double-Blind, Placebo-Controlled Study
Neurol 36:291-293, Staal-Schreinemachers,A.L.,et al, 1986
Dopamine D2 Receptor Density Remains Constant in Treated Parkinson's Disease
Ann Neurol 19:487-492, Guttman,M.,et al, 1986
Current Concepts in Brain Resuscitation
Arch Int Med 146:1413-1419, Kirsch,J.R.,et al, 1986
Drug Prescribing for Chronic Medical Disorders During Pregnancy:An Overview
J. P. , Am J Obstet Gynecol 155:565-56986., Rayburn,W.F.&Lavin,Jr, 1986
Acid Maltase Deficiency
Engel, A. G. in Engel and Banker, Myology, McGraw-Hill Co, New York, Ch 55, p. 1629-1651, , 1986
Dystonia-Parkinson Syndrome:Differential Effects of Levodopa and Dopamine Agonists
Clin Neuropharmacol 9:298-302, Klawans,H.L.&Paleologos,N., 1986
Extrapyramidal Reactions with Metoclopramide
BMJ 291:930-932, Bateman,D.N.,et al, 1985
Placebo-Controlled Study of Mesulergine in Parkinson's Disease
Neurol 35:161-165, Jankovic,J.,et al, 1985
Hyperthermia after Discontinuance of Levodopa & Bromocriptine Therapy:Impaired Dopamine Receptors a Possible Cause
Neurol 35:258-261, Figa-Talamanca,L.,et al, 1985
Prolactinomas
Editorial, BMJ 290:182-1841985., Grossman,A.,et al, 1985
Low Dosages of Bromocriptine Added to Levodopa in Parkinson's Disease
Neurol 35:199-206, Maier,M.M.,et al, 1985
Long-Term Study of Pergolide in Parkinson's Disease
Neurol 35:296-299, Jankovic,J., 1985
Randomized Clinical Trial of Atenolol in Patients with Alcohol Withdrawal
NEJM 313:905-909, Kraus,M.L.,et al, 1985
A Possible Teratogenic Effect of Propranolol
NEJM 313:518, Campbell,J.W., 1985
Low Doses of Dopamine Agonists in the Long-Term Treatment of Macroprolactinomas
NEJM 313:656-659, Liuzzi,A.,et al, 1985
Cerebrospinal Fluid Rhinorrhea During Treatment with Bromocriptine for Prolactinoma
Neurol 35:1193-1195, Kok,J.G.,et al, 1985
Clin. Path. Conference
Limbic Encephalitis (Paraneoplastic Encephalomyelitis) , Transitional-Cell CA of Urinary Bladder, Ca, e Re 30-1985,NEJM 313:249-257,1985., 1985
Low-Dose Bromocriptine Therapy in Parkinson's Disease
Arch Neurol 42:586-588, Pfeiffer,R.F.,et al, 1985
Mesulergin (CU32-085) in the Treatment of Parkinson's Disease
Ann Neurol 17:334-336, Pfeiffer,R.F.,et al, 1985
Carbonic Anhydrase II Deficiency in 12 Families with Osteopetrosis with Renal Tubular Acidosis & Cerebral Calcification
NEJM 313:139-181, Sly,W.S.,et al, 1985
Neuroleptic Malignant Syndrome
NEJM 313:163-166, Guze,B.H.,et al, 1985
Long-Acting Propranolol in Essential Tremor
Neurol 35:108-110, Koller,W.C., 1985
Propranolol Plasma Levels & Relief of Migraine
Arch Neurol 42:46-48, Cortelli,P.,et al, 1985
Calcium Channel Blockers in the Prophylactic Treatment of Vascular Headache
Ann Int Med 102:395-397, Meyer,J.S., 1985
Worsening of Myasthenia Gravis with Timolol Maleate Eyedrops
Ann Neurol 17:211-212, Verkijk,A., 1985
Muscarinic Acetylcholine Receptors in Alzheimer's Disease
JAMA 254:3063-3066, Holman,B.L.,et al, 1985
Dysosmia, Dysguesia, & Nifedipine
Ann Int Med 102:135-136, 7171985., Levenson,J.L.&Kennedy,K., 1985
Pimozide for Tourette's Disorder
Medical Letter 27:3-4, , 1985
Beta-Blockers and Glucose Control
Drug Intell Clin Pharm 19:246-251, Mills,G.A.&Horn,J.R., 1985
Neuroleptic Malignant Syndrome
Lancet 1:545-546, Smego,R.A.,et al, 1984
Psychotic Reactions During Treatment of Pituitary Tumours with Dopamine Agonists
BMJ 289:1101-1103, Turner,T.H.,et al, 1984
Effect of Dopamine Agonist Withdrawal After Long-Term Therapy in Prolactinomas
Lancet 2:187-192, Johnston,D.G.,et al, 1984
Flunarizine in Alternating Hemiplegia in Childhood
Lancet 2:579-580, Casaer,P.,et al, 1984
Verapamil in Prophylactic Therapy of Migraine
Neurol 34:973-976, Markley,H.G.,et al, 1984
Rapid Size Reduction of Giant Prolactinoma Following Medical Treatment
J Comput Assist Tomogr 8:131-133, Perani,D.,et al, 1984
Propranolol Therapy for Essential Tremor of the Head
Neurol 34:1077-1079, Koller,W.C., 1984
Metoclopramide & Tardive Dyskinesia in the Elderly
BMJ 289:397-398, Orme,M.L., 1984
Treatment of Tourette's Syndrome with R022-1913, A D-2-Receptor Antagonist
NEJM 311:989, Uhr,S.B.,et al, 1984
B Blockers & Loss of Hearing
BMJ 289:1490-1492, Faldt,R.,et al, 1984
Migraine Prevention with Timolol
JAMA 252:2576-2580, Stellar,S.,et al, 1984
B-Blockers & Migraine
JAMA 252:2614, Dalessio,D.J.,et al, 1984
Cerebrospinal Fluid Rhinorrhea Caused by Bromocriptine Therapy of Prolactinoma
Neurol 34:111-113, Holness,R.O.,et al, 1984
Treatment of Prolactinomas with Megavoltage Radiotherapy
BMJ 288:1105-1109, Grossman,A.,et al, 1984
Pergolide in the Treatment of Parkinson's Disease
Neurol 34:983-986, Mear,J.,et al, 1984